| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3945885 | Gynecologic Oncology | 2009 | 4 Pages |
Abstract
The combination of weekly topotecan and docetaxel has clinical benefit and is well tolerated in this heavily treated patient population. Patients with platinum-resistant tumors had clinical benefit and should be considered for further study with this regimen.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Divya Gupta, Ricky L. Owers, Mimi Kim, Dennis Yi-Shin Kuo, Gloria S. Huang, Shohreh Shahabi, Gary L. Goldberg, Mark H. Einstein,